Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium.

MLA

Choueiri, Toni K., et al. “Breakthrough SARS-CoV-2 Infections among Patients with Cancer Following Two and Three Doses of COVID-19 MRNA Vaccines: A Retrospective Observational Study from the COVID-19 and Cancer Consortium.” Lancet Regional Health. Americas, vol. 19, Mar. 2023, p. 100445. EBSCOhost, https://doi.org/10.1016/j.lana.2023.100445.

APA

Choueiri, T. K., Labaki, C., Bakouny, Z., Hsu, C.-Y., Schmidt, A. L., de Lima Lopes, G., Jr, Hwang, C., Singh, S. R. K., Jani, C., Weissmann, L. B., Griffiths, E. A., Halabi, S., Wu, U., Berg, S., O’Connor, T. E., Wise-Draper, T. M., Panagiotou, O. A., Klein, E. J., Joshi, M., … Warner, J. L. (2023). Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium. Lancet Regional Health. Americas, 19, 100445. https://doi.org/10.1016/j.lana.2023.100445

Chicago

Choueiri, Toni K, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L Schmidt, Gilberto de Lima Lopes Jr, Clara Hwang, et al. 2023. “Breakthrough SARS-CoV-2 Infections among Patients with Cancer Following Two and Three Doses of COVID-19 MRNA Vaccines: A Retrospective Observational Study from the COVID-19 and Cancer Consortium.” Lancet Regional Health. Americas 19 (March): 100445. doi:10.1016/j.lana.2023.100445.